Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

NegEnt: Cannabidiol-based Aromatherapy - Theoretical Aspects, Pharmacology, Clinical and Research Perspectives, Economic and Social Implications

Version 1 : Received: 7 June 2020 / Approved: 9 June 2020 / Online: 9 June 2020 (13:44:33 CEST)

How to cite: Scrimali, T. NegEnt: Cannabidiol-based Aromatherapy - Theoretical Aspects, Pharmacology, Clinical and Research Perspectives, Economic and Social Implications. Preprints 2020, 2020060124 (doi: 10.20944/preprints202006.0124.v1). Scrimali, T. NegEnt: Cannabidiol-based Aromatherapy - Theoretical Aspects, Pharmacology, Clinical and Research Perspectives, Economic and Social Implications. Preprints 2020, 2020060124 (doi: 10.20944/preprints202006.0124.v1).

Abstract

The article describes a research project that included the conception, development, testing and dissemination of a new drug, based on cannabidiol and called NegEnt (registered name and trademark).In this contribution, the author fully describes a new product for Aromatherapy that was developed and how it can be used for significant progress on various treatments for different conditions in psychiatry, neurology, and medicine. It also presents completed work for new herbal medicines at affordable costs worldwide.The clinical research program launched and the organizational and legal solutions identified are described to scientifically evaluate in accordance with a single case research study design. NegEnt's pharmacokinetics, bioavailability, pharmacodynamics, therapeutic efficacy, and tolerability is examined.In the last part of the article there is an outline of the project formulated for the development in Sicily in the province of Enna where NegEnt is produced in accordance with an innovative project of regional social promotion and based on the cultivation of cannabis Sativa Light, otherwise known as Progetto Demetra. This project established an operational module that is managed by a non-profit social enterprise called the Higher Institute for Cognitive Sciences, the ALETEIA LAB for Therapeutic cannabis, and as an ethical enterprise, which is called Herbal Neurocare (registered name and trademark). It contributes to improved health as well as promoting the economic and social development of this economically depressed area.

Supplementary and Associated Material

http://www.herbalneurocare.it: A start-up new Company

Subject Areas

therapeutic cannabis; cannabidiol; aromatherapy; NegEnt; Herbal Neurocare

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.